Researchers evaluated the time to first major renal event in over 13,000 patients with type 2 diabetes and atherosclerotic cardiovascular disease.

Among men with high-risk localized prostate cancer, those receiving neoadjuvant apalutamide combination therapy had improved potency recovery by 12 months and reduced rates of positive margins ...

She first had an episode of gross hematuria in her early 20’s. This was accompanied by flank pain, and she was given a course of empiric antibiotics. However, over the years, she has had multiple ...

Dr. Jeffery Taubenberger, who has been serving as acting head of the National Institute for Allergy and Infectious Diseases (NIAID) for just over a year, has stepped down for unknown reasons. It’s ...

Topline results from the phase 3 REDUCE 2 trial show that investigational pozdeutinurad effectively lowers serum uric acid in adults with gout.

A subgroup analysis of the PUSH trial sought to answer the research question: Does an incremental increase in urine volume provide benefit at different levels of baseline urine volume?

The FDA is reviewing an sBLA for nogapendekin alfa inbakicept-pmln plus BCG to treat BCG-unresponsive NMIBC with papillary disease without CIS.

The FDA has granted Priority Review to finerenone (Kerendia) for adults with type 1 diabetes and CKD, following FINE-ONE trial data showing a 25% reduction in UACR.

The Expander-2 trial randomly assigned men with BPH symptoms at 23 sites in the US and Canada to receive a temporary nitinol urethral implant, Urocross Expander, or a sham procedure.

An investigator reported 10-year follow-up data from a phase 3 trial of extended vs limited pelvic lymph node dissection during radical prostatectomy.

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has fired two key leaders of the task force that sets insurance coverage rules. Dr. John Wong, ...

Individuals with diabetes are at an increased risk of developing dementia, according to a study published in the June issue of Diabetes, Obesity and Metabolis ...